GL1X · GenesisL1 explorer

MolNFT v1 · #116503 · protein

Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036

5DFP · SERINE/THREONINE-protein kinase pak 1: “Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036”. X-ray diffraction, 1 ligand (59U), 2 pockets (best druggability 0.68). MolNFT v1 #116503 on GenesisL1: 3D structure…

PDB
5DFP
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase pak 1
EC
2.7.11.1
UniProt
Q13153
Ligands
59U
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase pak 1 (EC 2.7.11.1)protein29343% helix, 18% strandQ13153

Ligands and binding sites

  • 59U · 6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-8-ethyl-2-{[2-(1-methylpiperidin-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14280.680.804459U, DMS
2650.290.7319empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 5DFP · Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q13153 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase pak 1 (Q13153) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.